Recent News for BPTH - Bio-Path Holdings Inc

Date Title
Apr 12 Bio-Path Holdings Presents BP1002 Data at 2021 American Association for Cancer Research Annual Meeting
Apr 5 TSLA, NVTA, CHPT and NNOX among premarket gainers
Apr 5 Bio-Path Stock Is Trading Higher As Prexigebersen Triplet Combo Shows Favorable Safety Profile In Acute Myeloid Leukemia Study
Apr 5 Bio-Path shares rise after mid-stage leukemia trial update
Apr 5 Bio-Path Holdings Announces Successful Completion of Safety Cohort of Triple Combination of Prexigebersen, Decitabine and Venetoclax in Stage 2 of Phase 2 Clinical Trial in Acute Myeloid Leukemia
Mar 11 Bio-Path Holdings to Present at the 2021 American Association for Cancer Research Annual Meeting
Mar 10 Bio-Path Holdings, Inc (BPTH) CEO Peter Nielsen on Q4 2020 Results - Earnings Call Transcript
Mar 10 The Daily Biotech Pulse: MediciNova Bags BARDA Contract, Lilly's COVID-19 Antibody Cocktail Data, Bluebird Bio Refutes Blood Cancer Link
Mar 10 Bio-Path EPS beats by $0.21
Mar 10 Bio-Path Holdings Reports Full Year 2020 Financial Results
Mar 10 Bio-Path Holdings, Inc. to Host Earnings Call
Mar 10 Earnings Scheduled For March 10, 2021
Mar 6 The Week Ahead In Biotech (March 7-13): Conference Presentations And More Earnings
Mar 3 Bio-Path Holdings to Announce Full Year 2020 Financial Results on March 10, 2021
Feb 18 Bio-Path Holdings, Inc. Announces Closing of $13.0 Million Public Offering of Common Stock
Feb 16 Bio-Path slips 8% on capital raise
Feb 16 Bio-Path Holdings, Inc. Announces Pricing of $13.0 Million Public Offering of Common Stock
Feb 13 Bio-Path Holdings, Inc. Announces Proposed Public Offering of Common Stock
Feb 11 The Daily Biotech Pulse: DermTech Soars On Contract, Fluidigm Plunges On Earnings, Decision Day For Regeneron, Bioventus Debuts
Feb 11 44 Stocks Moving in Thursday's Pre-Market Session
Feb 10 Why Bio-Path's Stock Is Surging Higher Today
Feb 10 Mid-Day Market Update: US Stocks Turn Lower; Bio-Path Shares Jump
Feb 10 Bio-Path stock soars on U.S. patent grant
Feb 10 Bio-Path Quadruples on Receipt of Cancer-Drug Tech Patent
Feb 10 Bio-Path Receives Third U.S. Patent Grant Related to Manufacture of Platform Technology
Back to the Main BPTH Page...